Bisphosphonates for the prevention of osteoporosis in patients treated with systematic corticosteroids: a review of the clinical evidence and guidelines
Canadian Agency for Drugs and Technologies in Health
Record ID 32011001506
English
Authors' recommendations:
Evidence from three systematic reviews and seven randomized controlled trials suggested that bisphosphonates prevent bone loss associated with use of oral corticosteroids. However, one systematic review and one randomized controlled trial found that the reduction in non-vertebral fractures with bisphosphonates was not statistically significant.
Details
Project Status:
Completed
URL for project:
http://www.cadth.ca/media/pdf/htis/aug-2011/RC0293_bispho_final.pdf
Year Published:
2011
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Adrenal Cortex Hormones
- Osteoporosis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.